Siemens to Replace Healthineers CFO in Preparation for Listing Post author:Sam Post published:November 8, 2017 Post category:BioPharma The public listing that is expected to value the business at around $46 billion. Source: BioSpace You Might Also Like Massive FDA and NIH Cuts in Outlined Budget Plan May 22, 2017 Major Reorganization to Hit the NIH, Deep Cuts to Affect Thousands Under Budget Plan March 15, 2017 Deal Spree Continues as Allergan Inks $2.47 Billion Deal for This Bay Area Biotech February 12, 2017
